跳至主要内容
临床试验/DRKS00023311
DRKS00023311已完成不适用

Association of inflammatory markers in depressed patients with cognitive dysfunction - IMDEC

Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg0 个研究点目标入组 70 人开始时间: 2020年10月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • patients aged between 18 and 60 who are able to give consent
  • inpatient treatment due to a depressive episode (ICD-10 F31, F32, F33; HAMD-21: 18-30)
  • after written informed consent

排除标准

  • pregnant or brest-feeding women
  • drug or alcohol dependence
  • depressive episode secondary of a somatic/neurological illness or substance abuse
  • severe somatic or neurological illness which can impair results (e.g. Morbus Cushing, rheumathoid illness)
  • other psychiatric comorbidities
  • The patient cannot understand the scope of the study and is not capable of giving consent.
  • admission to hospital not voluntary
  • regular intake of steroids or non-steroidal antiphlogistics (NSAID)

研究者

发起方
Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg

相似试验

Association of inflammatory markers in depressed... | 临床试验